162 related articles for article (PubMed ID: 25897550)
1. Umeclidinium (Incruse Ellipta) for COPD.
Med Lett Drugs Ther; 2015 Apr; 57(1467):63-4. PubMed ID: 25897550
[No Abstract] [Full Text] [Related]
2. Umeclidinium (Incruse Ellipta) for COPD.
Durigan RC; Niedermier V
Am Fam Physician; 2017 Jan; 95(2):120-121. PubMed ID: 28084712
[No Abstract] [Full Text] [Related]
3. Anoro Ellipta: an inhaled umeclidinium/vilanterol combination for COPD.
Med Lett Drugs Ther; 2014 Apr; 56(1440):30-1. PubMed ID: 24736248
[No Abstract] [Full Text] [Related]
4. Umeclidinium for treating COPD: an evaluation of pharmacologic properties, safety and clinical use.
Manickam R; Asija A; Aronow WS
Expert Opin Drug Saf; 2014 Nov; 13(11):1555-61. PubMed ID: 25294427
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials.
Decramer M; Anzueto A; Kerwin E; Kaelin T; Richard N; Crater G; Tabberer M; Harris S; Church A
Lancet Respir Med; 2014 Jun; 2(6):472-86. PubMed ID: 24835833
[TBL] [Abstract][Full Text] [Related]
6. Spiriva Respimat--an oral inhalation spray for COPD.
Med Lett Drugs Ther; 2015 Mar; 57(1465):49-50. PubMed ID: 25853581
[No Abstract] [Full Text] [Related]
7. Aclidinium bromide: an alternative long-acting inhaled anticholinergic in the management of chronic obstructive pulmonary disease.
Woods JA; Nealy KL; Barrons RW
Ann Pharmacother; 2013; 47(7-8):1017-28. PubMed ID: 23737515
[TBL] [Abstract][Full Text] [Related]
8. Chronic obstructive pulmonary disease.
Kerstjens H; Postma D
Clin Evid; 2002 Jun; (7):1344-57. PubMed ID: 12243121
[No Abstract] [Full Text] [Related]
9. [Tiotropium bromide in the treatment of chronic obstructive lung disease].
Shmelev EI
Ter Arkh; 2003; 75(12):69-72. PubMed ID: 14959476
[No Abstract] [Full Text] [Related]
10. [COPD treatment by drugs].
Nafti S
Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S58-10S60. PubMed ID: 17127967
[No Abstract] [Full Text] [Related]
11. [Are there cardiovascular adverse effects of inhaled anticholinergics?].
Nagy LB
Orv Hetil; 2015 Aug; 156(31):1246-52. PubMed ID: 26211748
[TBL] [Abstract][Full Text] [Related]
12. Umeclidinium bromide and vilanterol in combination for the treatment of chronic obstructive pulmonary disease.
Kelly E
Expert Rev Clin Pharmacol; 2014 Jul; 7(4):403-13. PubMed ID: 24909949
[TBL] [Abstract][Full Text] [Related]
13. Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease.
Matera MG; Rogliani P; Rinaldi B; Cazzola M
Expert Rev Clin Pharmacol; 2015 Jan; 8(1):35-41. PubMed ID: 25382021
[TBL] [Abstract][Full Text] [Related]
14. Toward better COPD management: practical aspects of inhaler use.
Garvey C; Ortiz G; Yawn BP
Adv NPs PAs; 2011 Aug; 2(8):27-30, 32. PubMed ID: 21853640
[No Abstract] [Full Text] [Related]
15. Umeclidinium for the treatment of chronic obstructive pulmonary disease.
Segreti A; Calzetta L; Rogliani P; Cazzola M
Expert Rev Respir Med; 2014 Dec; 8(6):665-71. PubMed ID: 25312239
[TBL] [Abstract][Full Text] [Related]
16. The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects.
Feldman GJ; Edin A
Ther Adv Respir Dis; 2013 Dec; 7(6):311-9. PubMed ID: 24004659
[TBL] [Abstract][Full Text] [Related]
17. Use of inhaled anticholinergic agents in obstructive airway disease.
Restrepo RD
Respir Care; 2007 Jul; 52(7):833-51. PubMed ID: 17594728
[TBL] [Abstract][Full Text] [Related]
18. Inhaled anticholinergics for chronic obstructive pulmonary disease: comment on "Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease".
Singh S; Furberg CD
Arch Intern Med; 2011 May; 171(10):920-2. PubMed ID: 21606097
[No Abstract] [Full Text] [Related]
19. [The first long-acting anticholinergic drug. COPD drug with 24-hour effect].
MMW Fortschr Med; 2002 Jun; 144(26):52. PubMed ID: 12154479
[No Abstract] [Full Text] [Related]
20. 28-Day safety and tolerability of umeclidinium in combination with vilanterol in COPD: a randomized placebo-controlled trial.
Feldman G; Walker RR; Brooks J; Mehta R; Crater G
Pulm Pharmacol Ther; 2012 Dec; 25(6):465-71. PubMed ID: 22955035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
